"PHARMACEUTICAL COMPOSITION COMPRISING A LIPASE INHIBITOR AND A SUCROSE FATTY ACID ESTER"
Application 1902/CHENP/2003 published 2006-01-06, filed 2003-12-03
The present invention relates to a pharmaceutical composition comprising a lipase inhibitor, preferably orlistat, having a melting point =37°C, a sucrose fatty acid ester wherein the sucrose fatty acid ester is a mono-, di-, tri- or tetra-ester, and optionally one or more pharmaceutically acceptable recipients.
Applicant
F. HOFFMANN-LA ROCHE AG
Grenzacherstrasse 124, CH-4070 Basle, SWITZERLAND.
Inventor
International Info
Classification: A61K 31/365, 47/26, 9/20, A61P 3/04
Publication Number: PCT/EP02/05889
Priority Information
01113793.2 EUROPE 2001-06-06